The global biosensors market is expected to reach USD 34.51 billion in 2025 from USD 54.37 billion by 2030, growing at a CAGR of 9.5% during this period. Market growth is driven by the rising number of infectious diseases in developing countries, increasing demand for rapid diagnosis and efficient monitoring solutions, and technological advancements such as miniaturization, nanotechnology, microfluidics, and new product innovations. Additionally, the growing demand in urban areas, where diagnostic devices are easily accessible and simple to use, is further boosting market growth. Governments worldwide are launching initiatives to improve diagnostics and drug services, aiming to ensure availability and access to diagnostic testing while reducing patients’ out-of-pocket expenses.
“Embedded devices to account for the larger market share in 2030”
Embedded devices are commonly used in various applications such as point of care, home diagnostics, food and beverages, research labs, environmental monitoring, and biodefense. With the growth of the Internet of Things (IoT) devices, there has been a significant shift in connected healthcare applications. IoT enables real-time alerts, tracking, and monitoring, which allows for hands-on treatments, improved accuracy, timely interventions by doctors, and overall better patient care. Many healthcare facilities are beginning to adopt embedded solutions for medical devices with IoT capabilities to address the shortage of doctors in remote areas. These IoT-enabled medical devices help identify diseases and perform various tests to deliver accurate and reliable treatment to patients in remote locations. Consequently, the increasing use of embedded devices will boost the market growth of biosensors.
“Non-wearable (POC) biosensors to capture the largest share of the biosensors market throughout the forecast period”
The non-wearable biosensors market is a vibrant growth area driven by diverse applications, from handheld tools to lab systems and point-of-care diagnostics, vital in healthcare, environmental monitoring, and food safety. These biosensors, used in hospitals, research, food, and environmental sectors, enable real-time, on-site monitoring, helping address food quality challenges and meet safety standards. Market growth is fueled by increased awareness of environmental surveillance and the need for rapid devices for biodefense, food control, and pathogen detection.
“China to hold largest share in Asia Pacific of biosensors market in 2030”
The factors driving the biosensors market in China include rapid economic growth and an aging population, along with government efforts to improve healthcare services. Many multinational exporters and producers operating in China have adopted strategies such as acquisitions or strategic partnerships that support reliable domestic distribution and service infrastructure. In contrast, many domestic manufacturers, particularly those focused on export markets outside of China, lack strong distribution and service networks within the country. China is the most populous country in the world, and with the one-child policy, the elderly population is expected to increase in the future. As the population ages, there will likely be a significant rise in the incidence of various disorders, including heart diseases.
Extensive primary interviews were conducted with key industry experts in the biosensors market to determine and verify the market size for various segments and subsegments gathered through secondary research. The breakdown of primary participants for the report is shown below: The study includes insights from various industry experts, from component suppliers to Tier 1 companies and OEMs. The breakdown of the primary participants is as follows:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook